Back to Search Start Over

Patent Issued for Application of localized hypothermic therapy to a human head (USPTO 11813195).

Patent Issued for Application of localized hypothermic therapy to a human head (USPTO 11813195).

Source :
Pharma Business Week; 12/5/2023, p3682-3682, 1p
Publication Year :
2023

Abstract

A patent has been issued for the application of localized hypothermic therapy to a human head. The therapy involves cooling the structures of the human ear inside the skull to reduce inflammation and limit adverse effects related to injury. This therapy has shown promising results in reducing hearing damage, particularly in cases of noise-induced hearing loss. The patent describes an apparatus that can be applied to the ear to provide controlled and localized therapeutic hypothermia. The device can be used for various purposes, including preserving hearing and balance, treating ototoxic insults, traumatic brain injuries, and chemotherapy. [Extracted from the article]

Details

Language :
English
ISSN :
15436675
Database :
Complementary Index
Journal :
Pharma Business Week
Publication Type :
Periodical
Accession number :
173941359